glp-1 agonist and gastroparesis Drugs Gastroparesis: What Patients Should Know? GLP-1 Receptor Agonists Explained for

A reminder that their story doesnt start in Hollywood

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

Designed to complement your GLP-1 journey

Drugs like semaglutide and liraglutide have recently gained massive attention not just for diabetes, but for weight loss

Glucagon-like peptide-1 (GLP-1) receptor agonists have drawn a lot of interest lately for their therapeutic advantages over controlling blood sugar levels in the management of type 2 diabetes mellitus (T2DM)